药械指南

订阅

MedSci主页 / 所有栏目 / 药械指南

复杂性腹腔感染抗菌药物临床试验技术指导原则

2021-08-02 国家药品监督管理局药品审评中心（CDE） CDE

抗菌药物

复杂性腹腔感染抗菌药物临床试验技术指导原则

中文标题：

复杂性腹腔感染抗菌药物临床试验技术指导原则

发布机构：

国家药品监督管理局药品审评中心（CDE）

发布日期：

2021-08-02

简要介绍：

复杂性腹腔感染抗菌药物临床试验技术指导原则

相关资料下载：
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6a8161c002160555, title=复杂性腹腔感染抗菌药物临床试验技术指导原则, enTitle=, guiderFrom=CDE, authorId=0, author=, summary=复杂性腹腔感染抗菌药物临床试验技术指导原则, cover=, journalId=0, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心（CDE）, associationIntro=国家药品监督管理局药品审评中心（CDE）, copyright=0, guiderPublishedTime=Mon Aug 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>复杂性腹腔感染抗菌药物临床试验技术指导原则</p>, tagList=[TagDto(tagId=5642, tagName=抗菌药物)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1602, appHits=112, showAppHits=0, pcHits=256, showPcHits=1490, likes=1, shares=13, comments=7, approvalStatus=1, publishedTime=Mon Aug 23 17:39:56 CST 2021, publishedTimeString=2021-08-02, pcVisible=1, appVisible=1, editorId=4754896, editor=小小医者, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=小小医者, createdTime=Mon Aug 23 17:35:59 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Sat Jan 06 19:11:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1229184, encodeId=dfa4122918426, content=虚心学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4a88217689, createdName=ms3000001466593401, createdTime=Tue Jun 28 15:50:52 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190918, encodeId=34d01190918a8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=184c5266255, createdName=jessica26, createdTime=Tue Feb 08 08:24:14 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182960, encodeId=e1bc11829604f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82996400906, createdName=ms2000001826525154, createdTime=Mon Jan 10 21:23:10 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181659, encodeId=c52211816595e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211025/4aac53d3123446c5af3cebf4df126e53/db970580eb704431af00101c67ba359c.jpg, createdBy=c6221962164, createdName=1e13ac83m50(暂无匿称), createdTime=Fri Jan 07 00:16:31 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078699, encodeId=279d10e8699c1, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/CegvHbxjq9cwdKgw0ycuSNkstdWicibxLU8mDO1ZlSArG0HrTPWS1FxwCDcIkJTrgIy8YY6PGIoj4Rw6YBm8uEnw/132, createdBy=f6b82360124, createdName=chenhuijuan, createdTime=Fri Dec 10 10:24:26 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2022-06-28 ms3000001466593401

    虚心学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1229184, encodeId=dfa4122918426, content=虚心学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4a88217689, createdName=ms3000001466593401, createdTime=Tue Jun 28 15:50:52 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190918, encodeId=34d01190918a8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=184c5266255, createdName=jessica26, createdTime=Tue Feb 08 08:24:14 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182960, encodeId=e1bc11829604f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82996400906, createdName=ms2000001826525154, createdTime=Mon Jan 10 21:23:10 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181659, encodeId=c52211816595e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211025/4aac53d3123446c5af3cebf4df126e53/db970580eb704431af00101c67ba359c.jpg, createdBy=c6221962164, createdName=1e13ac83m50(暂无匿称), createdTime=Fri Jan 07 00:16:31 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078699, encodeId=279d10e8699c1, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/CegvHbxjq9cwdKgw0ycuSNkstdWicibxLU8mDO1ZlSArG0HrTPWS1FxwCDcIkJTrgIy8YY6PGIoj4Rw6YBm8uEnw/132, createdBy=f6b82360124, createdName=chenhuijuan, createdTime=Fri Dec 10 10:24:26 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2022-02-08 jessica26

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1229184, encodeId=dfa4122918426, content=虚心学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4a88217689, createdName=ms3000001466593401, createdTime=Tue Jun 28 15:50:52 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190918, encodeId=34d01190918a8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=184c5266255, createdName=jessica26, createdTime=Tue Feb 08 08:24:14 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182960, encodeId=e1bc11829604f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82996400906, createdName=ms2000001826525154, createdTime=Mon Jan 10 21:23:10 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181659, encodeId=c52211816595e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211025/4aac53d3123446c5af3cebf4df126e53/db970580eb704431af00101c67ba359c.jpg, createdBy=c6221962164, createdName=1e13ac83m50(暂无匿称), createdTime=Fri Jan 07 00:16:31 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078699, encodeId=279d10e8699c1, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/CegvHbxjq9cwdKgw0ycuSNkstdWicibxLU8mDO1ZlSArG0HrTPWS1FxwCDcIkJTrgIy8YY6PGIoj4Rw6YBm8uEnw/132, createdBy=f6b82360124, createdName=chenhuijuan, createdTime=Fri Dec 10 10:24:26 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2022-01-10 ms2000001826525154

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1229184, encodeId=dfa4122918426, content=虚心学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4a88217689, createdName=ms3000001466593401, createdTime=Tue Jun 28 15:50:52 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190918, encodeId=34d01190918a8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=184c5266255, createdName=jessica26, createdTime=Tue Feb 08 08:24:14 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182960, encodeId=e1bc11829604f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82996400906, createdName=ms2000001826525154, createdTime=Mon Jan 10 21:23:10 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181659, encodeId=c52211816595e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211025/4aac53d3123446c5af3cebf4df126e53/db970580eb704431af00101c67ba359c.jpg, createdBy=c6221962164, createdName=1e13ac83m50(暂无匿称), createdTime=Fri Jan 07 00:16:31 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078699, encodeId=279d10e8699c1, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/CegvHbxjq9cwdKgw0ycuSNkstdWicibxLU8mDO1ZlSArG0HrTPWS1FxwCDcIkJTrgIy8YY6PGIoj4Rw6YBm8uEnw/132, createdBy=f6b82360124, createdName=chenhuijuan, createdTime=Fri Dec 10 10:24:26 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2022-01-07 1e13ac83m50(暂无匿称)

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1229184, encodeId=dfa4122918426, content=虚心学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4a88217689, createdName=ms3000001466593401, createdTime=Tue Jun 28 15:50:52 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190918, encodeId=34d01190918a8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=184c5266255, createdName=jessica26, createdTime=Tue Feb 08 08:24:14 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182960, encodeId=e1bc11829604f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82996400906, createdName=ms2000001826525154, createdTime=Mon Jan 10 21:23:10 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181659, encodeId=c52211816595e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211025/4aac53d3123446c5af3cebf4df126e53/db970580eb704431af00101c67ba359c.jpg, createdBy=c6221962164, createdName=1e13ac83m50(暂无匿称), createdTime=Fri Jan 07 00:16:31 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078699, encodeId=279d10e8699c1, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/CegvHbxjq9cwdKgw0ycuSNkstdWicibxLU8mDO1ZlSArG0HrTPWS1FxwCDcIkJTrgIy8YY6PGIoj4Rw6YBm8uEnw/132, createdBy=f6b82360124, createdName=chenhuijuan, createdTime=Fri Dec 10 10:24:26 CST 2021, time=2021-12-10, status=1, ipAttribution=)]
    2021-12-10 chenhuijuan

    学习了！

    0

相关指南

抗菌药物临床试验微生物学实验技术指导原则

国家药品监督管理局药品审评中心（CDE） · 2020-12-31

2020 意见书：重症患者抗菌药物治疗监测

欧洲危重病医学会(ESICM,European Society of Intensive Care Medicine) · 2020-05-07

胆道外科抗菌药物规范化应用专家共识（2019版）

中华医学会外科学分会胆道外科学组 · 2019-07-25

2018 STM专家共识：抗菌药物在胸外科的应用

转化医学学会(STM,Society for Translational Medicine) · 2018-11-30

抗菌药物药代动力学/药效学理论临床应用专家共识

中国医药教育协会感染疾病专业委员会 · 2018-06-20

《创伤后抗菌药物预防使用专家共识》解读

暂未更新 · 2017-12-30